The Effect of Propranolol and Verapamil On Atrial and Atrioventricular Refractory Periods in Man

Hoffman BF , Siebens AA , Brooks C. McC: Effect of vagal stimulation on cardiac excitability. Am J Physiol. 169: 377-383, 1952.

Hoffman BF , Cranefield PF : The physiological basis of cardiac arrhythmias. Am J Med 37: 670-684, 1964.

Katz LN , Pick A. : Current status of theories of mechanisms of atrial tachycardias, flutter and fibrillation. Progr. Cardiovasc. Dis. 2: 650-662, 1960.

Watanabe Y. , Dreifus LS : Newer concepts in the genesis of cardiac arrhythmis. Am Heart J 76: 114-135, 1968.

Gettes LS : The electrophysiologic effects of antiarrhythmic drugs. Am J Cardiol. 28: 526-35, 1971.

Hayes, AH : The actions and clinical use of newer antiarrhythmic drugs. Ration. Drug Therapy 6: 1-6, 1972.

Singh BN , Vaughan Williams EM : A fourth class of anti-disrhythmic action? Cardiovasc. Research 6: 109-119, 1972.

Burn JH , Vaughan Williams EM , Walker JM : The production of block and auricular fibrillation in the heart-lung preparation by inhibitors of cholinesterase. Brit Heart J. 17: 431-447, 1955.

Loomis TA , Krop S. : Auricular fibrillation induced and maintained in animals by acetylcholine or vagal stimulation. Circ. Res. 3: 390-396, 1955.

Burn JH : Acetylcholine and cardiac fibrillation. Brit med Bull. 13: 181-184, 1957.

Szekeres L. , Papp GY : Experimental Cardiac Arrhythmias and Antiarrhythmic Drugs. p. 292 Akadémiai Kiadó, Budapest 1971.

Weidmann S. : Effects of calcium ions and local anesthetics on electrical properties of Purkinje fibres. J Physiol. 129: 568-582, 1955.

Johnson EA : The effects of quinidine, procaine amide and pyrilamine on the membrane resting and action potential of guinea pig ventricular muscle fibers. J. Pharmacol. 117: 237-244, 1956.

Vaugham Williams EM : The mode of action of quinidine on isolated rabbit atria interpreted from intracellular potential records. Brit J Pharmacol. 13: 276-287, 1958.

Conn HL Jr: Some considerations of quinidine and procaine amid action at cellular level . In: Briller SA and Conn HL (Ed) The Myocardial Cell, Phil. 1966, p. 269.

Mason DT , Spann JF , Zelis R. and Amsterdam EA : The clinical pharmacology and therapeutic application of the anti-arrhythmic drugs. Clin Pharmacol Therap. 11: 460-480, 1970.

Singer DH , Eick Ret : Pharmacology of cardiac arrhythmias. Progr. Cardiov. Dis. 11: 488-511, 1969.

Basset AL , Hoffman BF : Anti-arrhythmic drugs: Electrophysiological actions. Ann. Rev. Pharm. 11: 143-170, 1971.

Pick A. : Mechanisms of cardiac arrhythmias: From hypothesis to physiologic fact. Am Heart J 86: 249-269, 1973.

Wit AL , Weiss MB , Berkowitz WD , Rosen KM , Steiner C. , Damato, AN : Patterns of atrioventricular conduction in the human heart. Circ. Res. 27: 345-359, 1970.

Dawes GS , Vane JR : The refractory period of atria isolated from mammalian hearts. J. Physiol. 132: 611-629, 1956.

Hoffmann BF , Cranefield PF : Electrophysiology of the Heart p. 51-52 McGraw-Hill Book Comp. Inc. New York 1960.

Cagin NA , Kunstadt D. , Wolfish P. , Levitt B. : The influence of heart rate on the refractory period of the atrium and A-V conducting system. Am Heart J. 85: 358-366, 1973.

Rosen KM : Catheter recording of His bundle electrograms. Modern Concepts Cardiovasc. Dis. 42: 23-28, 1973.

Josephson ME , Caracta AR , Lau SH , Gallagher JJ , Damato AN : Effects of lidocain on refractory periods in man. Am Heart J 84: 778-86, 1972.

Caracta AR , Damato AN , Josephson ME , Ricciutti MA , Gallagher, JJ , Lau SH : Electrophysiologic properties of diphenylhydantoin. Circulation 47: 1234-41, 1973.

Morales-Aquilera A. , Vaughan Williams EM: The effects on cardiac muscle of beta-receptor antagonists in relation to their activity as local anaesthetics. Brit J Pharmacol. 24:332-338, 1965.

Vaughan Williams EM : Mode of action of beta receptor antagonists on cardiac muscle. Am J Cardiol 18: 399-405, 1966.

Hoffman BF , Singer DH : Appraisal of the effects of catecholamines on cardiac electrical activity . Ann NY Acad Sci 1939: 914-939, 1967.

Davis LD , Temte JV : Effects of propranolol on the transmembrane potentials of ventricular muscle and Purkinje fibers of the dog. Circ. Res. 22: 661-77, 1968.

Gettes LS , Surawicz B. : Long term prevention of paroxysmal arrhythmias with propranolol therapy. Am J Med Sci 254: 257-65, 1967.

Stern S. , Eisenberg S. : The effect of propranolol (Inderal) on the electrocardiogram of normal subjects . Am Heart J 77: 192-195, 1969.

Damato AN , Lau SH : Clinical value of the electrogram of the conducting system. Progr Cardiovasc Dis 13: 119-140, 1970.

Surawicz B. , Lasseter KC : Effects of drugs on the electrocardiogram . Progr Cardiovasc Dis 13: 26-55, 1970.

Berkowitz WD , Wit AL , Lau SH , Steiner C. , Damato AN : The effects of propranolol on cardiac conduction . Circulation 40: 855-862, 1969.

Melville KI , Shister HE , Huq S. : Iproveratril: Experimental data on coronary dilatation and antiarrhythmic action. Canad Med Ass J 90: 761-770, 1964.

Schmid JR , Hanna C. : A comparison of the antiarrhythmic actions of two new synthetic compounds, iproveratril and MJ 1999, with quinidine and pronethalol. J Pharmac exp Ther 156: 331-338, 1967.

Rodrigues-Pereira E. , Viana AP : The actions of verapamil on experimental arrhythmias. Arzneimittel-Forschung 18: 175-179, 1968.

Hanna C. , Schmid JR : Antiarrhythmic actions of coronary vasodilator agents, papaverine, dioxyline and verapamil. Arch int Pharmacodyn 185: 228-233, 1970.

Bender F. , Kojima N. , Reploh H. , Oelman G. : Behandlung tachykarder Rhythmusstörungen des Herzens durch Beta-Rezeptoren-blockade des Atrioventrikulargewebes. Med Welt 17: 1120-1123, 1966.

Bender F. : Isoptin zur Behandlung der tachykarden Form des Vorhofflatterns. Med Klin 62: 634-636, 1967.

Oram S. , Catley PF , Lindsley B. , Kidner PH : An antidysrhythmic agent. Brit Med J 4: 113, 1971.

Schamroth L. , Krikler DM , Garret C. : Immediate effects of intravenous verapamil in cardiac arrhythmias. Brit Med J 1: 660-662, 1972.

Bass O. , Friedman M. : Ein Betrag zum antiarrhythmischen Wirkungsmechanismus von Verapamil (Isoptin) . Schweiz. med. Wschr. 101: 792-799.

Garvey HL : The mechanism of action of verapamil on the sinus and AV nodes. Europ J Pharm 8: 159-166, 1969.

Fleckenstein A. , Döring HJ , Kammermeier H. : Einfluss von Beta-Receptorblockern und verwandten Substanzen auf Erregung, Kontraktion und Energiestoffwechsel der Myokardfaser . Klinische Wochenshr. 46: 343-351, 1968.

Graca AS , van Zwieten PA : The influence of ipoveratril on calcium movements in isolated heart muscle . Europ J Pharm 15: 137-140, 1971.

Rydén L. , Saetre H. : The hemodynamic effect of verapamil Europ J clin Pharmacol. 3: 153-157, 1971.